 | • レポートコード：MRC2304F083 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、250ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートによると、2021年に1,291.31百万ドルであった世界の動物用ポイントオブケア（POC）診断市場規模は2022年に1,485.92百万ドルになり、更に年平均15.32％拡大して2027年までに3,037.90百万ドルに達する見通しです。本書は、動物用ポイントオブケア（POC）診断の世界市場についての多面的な調査を元に、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別（消耗品、器具）分析、技術別（臨床生化学診断、血液診断、免疫診断、分子診断）分析、サンプル種類別（血液/血漿/血清、便、尿）分析、動物種類別（伴侶動物、家畜動物）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの内容をまとめた市場調査レポートです。なお、本書に掲載されている企業情報には、AccuBioTech Co., Ltd.、AniPOC, Ltd.、Chembio Diagnostic Systems, Inc.、Esaote SpA、FUJIFILM Holdings Corporation、Heska Corporation、IDEXX Laboratories, Inc.、Koninklijke Philips N.V.、Mindray Medical International Limitedなどが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の動物用ポイントオブケア（POC）診断市場規模：製品別 - 消耗品の市場規模 - 器具の市場規模 ・世界の動物用ポイントオブケア（POC）診断市場規模：技術別 - 臨床生化学診断の市場規模 - 血液診断の市場規模 - 免疫診断の市場規模 - 分子診断の市場規模 ・世界の動物用ポイントオブケア（POC）診断市場規模：サンプル種類別 - 血液/血漿/血清検査診断の市場規模 - 便検査診断の市場規模 - 尿検査診断の市場規模 ・世界の動物用ポイントオブケア（POC）診断市場規模：動物種類別 - 伴侶動物における市場規模 - 家畜動物における市場規模 ・世界の動物用ポイントオブケア（POC）診断市場規模：地域別 - 南北アメリカの動物用ポイントオブケア（POC）診断市場規模 アメリカの動物用ポイントオブケア（POC）診断市場規模 カナダの動物用ポイントオブケア（POC）診断市場規模 ブラジルの動物用ポイントオブケア（POC）診断市場規模 ... - アジア太平洋の動物用ポイントオブケア（POC）診断市場規模 日本の動物用ポイントオブケア（POC）診断市場規模 中国の動物用ポイントオブケア（POC）診断市場規模 インドの動物用ポイントオブケア（POC）診断市場規模 韓国の動物用ポイントオブケア（POC）診断市場規模 台湾の動物用ポイントオブケア（POC）診断市場規模 ... - ヨーロッパ/中東/アフリカの動物用ポイントオブケア（POC）診断市場規模 イギリスの動物用ポイントオブケア（POC）診断市場規模 ドイツの動物用ポイントオブケア（POC）診断市場規模 フランスの動物用ポイントオブケア（POC）診断市場規模 ロシアの動物用ポイントオブケア（POC）診断市場規模 ... - その他地域の動物用ポイントオブケア（POC）診断市場規模 ・競争状況 ・企業情報 |
The Global Veterinary Point Of Care Diagnostics Market size was estimated at USD 1,291.31 million in 2021 and expected to reach USD 1,485.92 million in 2022, and is projected to grow at a CAGR 15.32% to reach USD 3,037.90 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Veterinary Point Of Care Diagnostics to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Consumables and Instruments.
Based on Technology, the market was studied across Clinical Biochemistry, Hematology, Immunodiagnostics, and Molecular Diagnostics.
Based on Sample Type, the market was studied across Blood/Plasma/Serum, Fecal, and Urine.
Based on Animal Type, the market was studied across Companion Animals and Livestock Animals. The Companion Animals is further studied across Cats, Dogs, and Horses. The Livestock Animals is further studied across Cattle, Poultry, and Swine.
Based on Application, the market was studied across Bacteriology, Clinical Pathology, Parasitology, and Virology.
Based on End-User, the market was studied across Home Care Settings, Veterinary Clinics, and Veterinary Hospitals and Academic Institutes.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Veterinary Point Of Care Diagnostics market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Veterinary Point Of Care Diagnostics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Veterinary Point Of Care Diagnostics Market, including AccuBioTech Co., Ltd., AniPOC, Ltd., Chembio Diagnostic Systems, Inc., Esaote SpA, FUJIFILM Holdings Corporation, Heska Corporation, IDEXX Laboratories, Inc., Koninklijke Philips N.V., Mindray Medical International Limited, Neogen Corporation, Nova Biomedical Corporation, Novartis AG, Randox Laboratories LTD., Siemens AG, Virbac Corporation, Woodley Equipment Company, Woodley Equipment Company Inc, and Zoetis, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Veterinary Point Of Care Diagnostics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Veterinary Point Of Care Diagnostics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Veterinary Point Of Care Diagnostics Market?
4. What is the competitive strategic window for opportunities in the Global Veterinary Point Of Care Diagnostics Market?
5. What are the technology trends and regulatory frameworks in the Global Veterinary Point Of Care Diagnostics Market?
6. What is the market share of the leading vendors in the Global Veterinary Point Of Care Diagnostics Market?
7. What modes and strategic moves are considered suitable for entering the Global Veterinary Point Of Care Diagnostics Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of zoonotic diseases among companion and livestock animals
5.1.1.2. Increasing adoption of pet animals along with the rising population of livestock animal
5.1.1.3. Need for pet insurance and growing animal health expenses
5.1.2. Restraints
5.1.2.1. High cost of veterinary imaging instruments
5.1.3. Opportunities
5.1.3.1. Rapid growth in pet care expenditure
5.1.3.2. Availability of technologically advanced diagnostic tests
5.1.4. Challenges
5.1.4.1. Limited animal health awareness and shortage of veterinarians
5.2. Cumulative Impact of COVID-19
6. Veterinary Point Of Care Diagnostics Market, by Product
6.1. Introduction
6.2. Consumables
6.3. Instruments
7. Veterinary Point Of Care Diagnostics Market, by Technology
7.1. Introduction
7.2. Clinical Biochemistry
7.3. Hematology
7.4. Immunodiagnostics
7.5. Molecular Diagnostics
8. Veterinary Point Of Care Diagnostics Market, by Sample Type
8.1. Introduction
8.2. Blood/Plasma/Serum
8.3. Fecal
8.4. Urine
9. Veterinary Point Of Care Diagnostics Market, by Animal Type
9.1. Introduction
9.2. Companion Animals
9.3.1. Cats
9.3.2. Dogs
9.3.3. Horses
9.3. Livestock Animals
9.4.1. Cattle
9.4.2. Poultry
9.4.3. Swine
10. Veterinary Point Of Care Diagnostics Market, by Application
10.1. Introduction
10.2. Bacteriology
10.3. Clinical Pathology
10.4. Parasitology
10.5. Virology
11. Veterinary Point Of Care Diagnostics Market, by End-User
11.1. Introduction
11.2. Home Care Settings
11.3. Veterinary Clinics
11.4. Veterinary Hospitals and Academic Institutes
12. Americas Veterinary Point Of Care Diagnostics Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Veterinary Point Of Care Diagnostics Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Veterinary Point Of Care Diagnostics Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis, By Key Player
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion
16. Company Usability Profiles
16.1. AccuBioTech Co., Ltd.
16.1.1. Business Overview
16.1.2. Key Executives
16.1.3. Product & Services
16.2. AniPOC, Ltd.
16.2.1. Business Overview
16.2.2. Key Executives
16.2.3. Product & Services
16.3. Chembio Diagnostic Systems, Inc.
16.3.1. Business Overview
16.3.2. Key Executives
16.3.3. Product & Services
16.4. Esaote SpA
16.4.1. Business Overview
16.4.2. Key Executives
16.4.3. Product & Services
16.5. FUJIFILM Holdings Corporation
16.5.1. Business Overview
16.5.2. Key Executives
16.5.3. Product & Services
16.6. Heska Corporation
16.6.1. Business Overview
16.6.2. Key Executives
16.6.3. Product & Services
16.7. IDEXX Laboratories, Inc.
16.7.1. Business Overview
16.7.2. Key Executives
16.7.3. Product & Services
16.8. Koninklijke Philips N.V.
16.8.1. Business Overview
16.8.2. Key Executives
16.8.3. Product & Services
16.9. Mindray Medical International Limited
16.9.1. Business Overview
16.9.2. Key Executives
16.9.3. Product & Services
16.10. Neogen Corporation
16.10.1. Business Overview
16.10.2. Key Executives
16.10.3. Product & Services
16.11. Nova Biomedical Corporation
16.11.1. Business Overview
16.11.2. Key Executives
16.11.3. Product & Services
16.12. Novartis AG
16.12.1. Business Overview
16.12.2. Key Executives
16.12.3. Product & Services
16.13. Randox Laboratories LTD.
16.13.1. Business Overview
16.13.2. Key Executives
16.13.3. Product & Services
16.14. Siemens AG
16.14.1. Business Overview
16.14.2. Key Executives
16.14.3. Product & Services
16.15. Virbac Corporation
16.15.1. Business Overview
16.15.2. Key Executives
16.15.3. Product & Services
16.16. Woodley Equipment Company
16.16.1. Business Overview
16.16.2. Key Executives
16.16.3. Product & Services
16.17. Woodley Equipment Company Inc
16.17.1. Business Overview
16.17.2. Key Executives
16.17.3. Product & Services
16.18. Zoetis, Inc.
16.18.1. Business Overview
16.18.2. Key Executives
16.18.3. Product & Services
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing
